Meeting
2020 Gastrointestinal Cancers Symposium
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
Authors
Matthew B. Yurgelun
Dana-Farber Cancer Institute, Boston, MA
Matthew B. Yurgelun , Chinedu I. Ukaegbu , C. Sloane Furniss , Barbara Kenner , Alison Klein , Andrew M. Lowy , Florencia McAllister , Maureen E Mork , Scott H. Nelson , Alison Robertson , Jill E. Stopfer , Meghan Underhill , Allyson J. Ocean , Lisa Madlensky , Gloria M. Petersen , Judy Ellen Garber , Scott Michael Lippman , Michael Goggins , Anirban Maitra , Sapna Syngal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
NCT03762590
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr TPS779)
Abstract #
TPS779
Poster Bd #
P22
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2018 ASCO Annual Meeting
High prevalence of hereditary cancer syndromes and outcomes in adults with early-onset pancreatic cancer.
First Author: Maria Fernanda Montiel
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian